Table 6.

Fisetin in clinical trials for inflammatory disorders.

Status	Study Title	Conditions	Intervention	Phase	NCT Number
Recruiting	Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Adults	Frail Elderly Syndrome	20 mg/kg daily orally for 2 consecutive days	Phase 2	NCT03675724
Recruiting	Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women	Frail Elderly Syndrome	20 mg/kg daily orally for 2 consecutive days, for 2 consecutive months.	Phase 2	NCT03430037
Recruiting	Senolytic Drugs Attenuate Osteoarthritis-Related Articular Cartilage Degeneration: A Clinical Trial	Osteoarthritis, Knee	20 mg/kg for 2 consecutive days, followed by 28 days off, then 2 more consecutive days	Phase 1/2	NCT04210986
Recruiting	Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease	Chronic Kidney Diseases, Diabetes Mellitus, Diabetic Nephropathies	20 mg/kg daily orally for 2 consecutive days	Phase 2	NCT03325322